nexalel

Genomics and microbiome intelligence for high-volume programs

From the sequenced genome to a decision that stands up to review.

Once a program sequences hundreds or thousands of genomes a month, producing data stops being the hard part. Turning it into evidence that is traceable, comparable and analytically sound enough for decisions with clinical, public-health or environmental consequences is.

Verifiable proof

Every figure on this page opens its provenance

Original files, versions and hashes one click away, with no sign-up.

1

reproducible synthetic cohort

60

verifiable synthetic samples

90

features in the count table

52

public files with SHA-256

What held up

A diversity signal holds under the documented depth check.

What did not hold up

Of the two significant contrasts, neither survived the sensitivity test. We publish that too.

Download the synthetic tables and test the analysis ↓ · 0.01 MB · No account, no form and no sales call.

The problem

Sequencing is no longer the bottleneck

Volume outruns the capacity to review.

Thousands of samples produce more results than any team can read with judgement. Without a layer that prioritises and documents, quality depends on who is reviewing that day.

Every batch changes the method without anyone deciding it.

References, versions and annotators drift between deliveries, and technical differences end up mistaken for biological findings.

Insight without provenance cannot carry a decision.

A result that cannot be rerun or audited is of no use to a clinical committee, a health authority or an external reviewer.

Nexalel turns that flow into evidence: analyses with frozen methods, comparisons that separate signal from artefact, and packages a third party can verify and run again.

What we deliver

Three outcomes a program can demand

Reproduce, compare and substantiate, with public cases you can examine today. Scope and feasibility are agreed for every study before a single file is processed.

01

Reproduce

Check which results reproduce and document the discrepancies.

View deliverable and scope

A rerun record, a citable package and a method contract with frozen versions.

Available

Computed today on public microbiome data. In genomics, the public demonstration uses synthetic annotation; real sources are agreed by contract.

02

Compare

Assess what can be compared and which differences prevent a conclusion.

View deliverable and scope

A processed cohort, a declared comparison and an explicit list of what the comparison does not allow you to conclude.

Available

The public 16S atlas can be consulted. Comparing a new cohort requires a compatibility assessment and an agreed method; it is not a self-service capability.

03

Substantiate

A report that connects each conclusion to its evidence and its limits.

View deliverable and scope

A report that separates observation, inference and interpretation, with the intended use stated in writing.

Available

The format is published and can be downloaded from the public microbiome case.

Who we serve

Built for teams that sequence at scale

National programs, hospitals, laboratories, industry and funders share the same problem with different urgency. Pick the starting point that looks most like yours.

How it works

From the question to a reviewable package

  1. 01

    Agree

    We define the question, the assay, the data rights and the acceptance criteria together.

  2. 02

    Review

    We check inputs, method and feasibility before anything is processed.

  3. 03

    Document

    Results, versions, provenance and uncertainty are recorded in the same package.

  4. 04

    Deliver

    A dossier another team can verify and run again, together with the record of what did not hold up.

See how it works ↗

What does your next study have to demonstrate?

We first agree on the question, the assay, the data rights and the deliverable. Then we decide whether working together makes sense.